Celgene's Revlimid falls short at NICE; Omnicare to pay $120M in kickback probe;

@FiercePharma: Roche is putting $900M into biologics manufacturing, but turning to Samsung for some of its drugs. News | Follow @FiercePharma

@CarlyHFierce: Here's FiercePharmaManufacturing's take on McKesson's Celesio buyout. More | Follow @CarlyHFierce

> The U.K.'s cost-effectiveness watchdogs refused to back Celgene's ($CELG) blood cancer drug Revlimid for a new use in a rare bone marrow disorder. Report

> Omnicare agreed to pay $120 million to settle a U.S. kickback lawsuit, which alleges that the pharmacy services provider gave nursing homes heavily discounted drugs in exchange for patient referrals. Report

> Cubist Pharmaceuticals ($CBST) posted third-quarter earnings of 41 cents per share, far short of the expected 55 cents, because of higher expenses; sales rose by 12% to $266 million. Report

> The FDA said it's completing its phase-out of all drug inhalers containing CFCs by Dec. 31 to comply with an international treaty. Release

> Sanofi ($SNY) moved all its human resources operations in more than 100 countries into the cloud to allow for new global processes and data analytics. Report

> China's Sinopharm said its 9-month net profit rose 17.5%. Report

> GlaxoSmithKline ($GSK) is eyeing a new advertising agency for its global digital advertising. Report

> Novo Nordisk ($NVO) said it's worried about illegal online sales of its growth hormone, some of which probably isn't genuine. Report

> The U.K.'s National Health Service hired Simon Stevens to take over as CEO next year; Stevens currently heads up the global health division of U.S.-based insurer UnitedHealth. Report

> As it prepares to be acquired by Perrigo ($PRGO), Elan ($ELN) posted earnings before interest and taxes of $12.1 million and said it has $1.9 billion in cash on hand. Report

Medical Device News

@FierceMedDev: UPDATED: Boston Scientific to slash up to 1,500 more jobs even as Q3 numbers improve. Story | Follow @FierceMedDev

@MarkHFierce: Check out this week's FierceDiagnostics newsletter | Follow @MarkHFierce

@MichaelGFierce: Layered nanoparticles deliver RNA, chemo for one-two punch. Item from FierceDrugDelivery | Follow @MichaelGFierce

> Med tech VC Versant raising $250M new fund amid sluggish market. Story

> Vitamin B2 may help build a safer 3-D medical implant. Item

> Zimmer lowers outlook as profits slide despite ortho growth. Report

> DeCODE spinout raises $15M to bring gene sequencing into daily Dx. Article

Biotech News

@FierceBiotech: ICYMI yesterday: The top 10 biotech IPOs of 2013. Special report | Follow @FierceBiotech

@JohnCFierce: Rigel sinks after adding another trial failure to its losing streak. News | Follow @JohnCFierce

@DamianFierce: Repros tanks as FDA scrutiny of testosterone drug pushes back NDA date. ICYMI yesterday | Follow @DamianFierce

@EmilyMFierce: ICYMI: Takeda, Hopkins developing new pancreatic cancer drugs. More from FierceBiotech Research | Follow @EmilyMFierce

> Armed-antibody successes inspire a burst of new building projects, industry deals. More

> Troubled Merck shrugs off fresh doubts about late-stage heart drug. Article

> Bristol-Myers exec sentenced to a year in prison on insider trading scheme. Report

> AstraZeneca plans to shutter lab, ax staffers. Item

Pharma Manufacturing News

@EricPFierce: Samsung, which has worked on a biosimilar of Rituxan, has a new deal to make biologics for Roche. Article | Follow @EricPFierce

> Stolen Novo growth hormone sold on Internet. Item

> McKesson makes $8.3B move on Europe. Story

> Actis invests $48M in API maker Symbiotec. News

> Hospira unveils new quality lab at troubled plant. More

Vaccines News

> Finnish team talks up prospects of Type 1 diabetes vaccine. Report

> Study finds herd immunity protects babies against whooping cough. More

> Meta-analysis links flu vaccine to lower risk of heart attack and stroke. Article

> Timing of first measles vaccine dose linked to effectiveness. Item

> Taliban anti-vaccine push raises risk of polio outbreak. Story

And Finally... Prostate cancer radiation therapy is more commonly prescribed by urologists who own their own equipment to provide the treatment. Report

Suggested Articles

Former Indivior CEO Shaun Thaxter will face six months in federal prison for his role in misleading government officials on the dangers of Suboxone.

As of Friday after local time, 36 people have died in Korea after getting flu shots provided by at least seven companies, including Sanofi.

Two prominent pneumococcal vaccines from Merck and Pfizer are running low in Europe in a possible ill omen for the coming winter: report.